Unknown

Dataset Information

0

Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera.

ABSTRACT:

SUBMITTER: Liu D 

PROVIDER: S-EPMC8448748 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation.
| S-EPMC1434515 | biostudies-literature
Unknown Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F.
| S-EPMC4979103 | biostudies-literature
Unknown Decrease in JAK2 V617F allele burden is not a prerequisite to clinical response in patients with polycythemia vera.
| S-EPMC3347655 | biostudies-literature
Unknown Development and inter-laboratory validation of unlabeled probe melting curve analysis for detection of JAK2 V617F mutation in polycythemia vera.
| S-EPMC3197667 | biostudies-literature
Unknown A Polycythemia Vera JAK2 Mutation Masquerading as a Duodenal Cancer Mutation.
| S-EPMC7385920 | biostudies-literature
Unknown A phase 1 study of the Janus kinase 2 (JAK2)<sup>V617F</sup> inhibitor, gandotinib (LY2784544), in patients with primary myelofibrosis, polycythemia vera, and essential thrombocythemia.
| S-EPMC8207330 | biostudies-literature
Unknown Efficacious intermittent dosing of a novel JAK2 inhibitor in mouse models of polycythemia vera.
| S-EPMC3356383 | biostudies-literature
Unknown Transient expansion of TP53 mutated clones in polycythemia vera patients treated with idasanutlin.
| S-EPMC7686898 | biostudies-literature
Unknown Bone marrow stroma-secreted cytokines protect JAK2(V617F)-mutated cells from the effects of a JAK2 inhibitor.
| S-EPMC4067142 | biostudies-literature
Unknown Platelet Dysfunction and Thrombosis in JAK2<sup>V617F</sup>-Mutated Primary Myelofibrotic Mice.
| S-EPMC7605151 | biostudies-literature